Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: UV4.me2
Total 0 results
Nothing found
Sponsors and Collaborators
delta medical promotions ag
WillowWood Global LLC
the Regional Direction of Clinical Research
HMO Gesundheitsplan Basel, Switzerland
mHealth Impact Lab
Hangzhou Neoantigen Therapeutics Co., Ltd.
London Metropolitan University
Washington State Attorney General's Office
IRCCS San Raffaele Roma
Dermatologic Surgery Center of Washington LLC and Skin Cancer Treatment Center
Stefano Rizza
Universidad de Chile (UChile, Chile)
Marealis AS
Pedro Rodrigues Genta
Nuseed Americas Inc.
Peijas Hospital
Hoffmann-La Roche
Gynea Laboratorios SA
Center for HIV/AIDS Vaccine Immunology
Advanced Reconstructive Surgery Alliance
View Full List
Medical Conditions
Urticaria Chronic
Deep Hypothermic Circulatory Arrest
Retinal Surgery
Orthopedics
Depressive; Disorder, Major, Single Episode, Major, With Psychotic Symptoms
Mindfulness-based Intervention
Delivery
Philadelphia Chromosome
Low-dose Corticosteroids Pretreatment
Adult Oligoastrocytoma
Infantile GM2 Gangliosidosis (Disorder)
Peroxisomal Disorders
Mitochondrial DNA Mutation
Neoplasms, Urethral
Hypopigmented Skin
The Angle of Trunk Rotation in Thoracic Part
Type D Personality
Perforation of Eardrum.
Congenital Heart Disease in Children
Shoulder Arthroscopy Blocks
View Full List
Drug Interventions
Vincristine
Yohimbine hydrochloride
Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets
BIC/FTC/TAF
Atorvastatin
MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate (q1w regimen)
Silymarin (Silybum marianum)
Immediate-release nicotinamide (SAD)
Metronidazole
Amivantamab
Simvastatin
Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF)
Ibrutinib
Neridronate
RhGM-CSF
Etoposide
Rituxumab
Basiliximab
Active Comparator: TU2670 320mg
Delamanid
View Full List
CROs by country
Contract Research Organizations in Algeria
Contract Research Organizations in Azerbaijan
Contract Research Organizations in Belgium
Contract Research Organizations in Bosnia & Herzegovina
Contract Research Organizations in Burundi
Contract Research Organizations in Latvia
Contract Research Organizations in Portugal
Contract Research Organizations in South Africa
Contract Research Organizations in Spain
Contract Research Organizations in Trinidad & Tobago
Contract Research Organizations in United Arab Emirates
Contract Research Organizations in United States
Contract Research Organizations in Venezuela
CRO list by country
CROs in Montenegro
BiTrial Clinical Research
SGS
Clinres Farmacija
All CROs in Montenegro
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe